Laboratorios Farmaceuticos Rovi, S.A. (BIT:1ROVI)
65.05
0.00 (0.00%)
Last updated: Oct 31, 2025, 9:00 AM CET
BIT:1ROVI Revenue
Laboratorios Farmaceuticos Rovi had revenue of 159.70M EUR in the quarter ending June 30, 2025, a decrease of -10.36%. This brings the company's revenue in the last twelve months to 749.00M, down -3.73% year-over-year. In the year 2024, Laboratorios Farmaceuticos Rovi had annual revenue of 763.75M, down -7.93%.
Revenue (ttm)
749.00M
Revenue Growth
-3.73%
P/S Ratio
4.17
Revenue / Employee
342.32K
Employees
2,197
Market Cap
3.13B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 763.75M | -65.76M | -7.93% |
| Dec 31, 2023 | 829.51M | 11.81M | 1.44% |
| Dec 31, 2022 | 817.70M | 169.02M | 26.06% |
| Dec 31, 2021 | 648.68M | 228.72M | 54.46% |
| Dec 31, 2020 | 419.96M | 38.65M | 10.14% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Stellantis | 146.12B |
| Eni S.p.A. | 86.56B |
| Enel SpA | 77.79B |
| Assicurazioni Generali | 56.79B |
| Intesa Sanpaolo | 25.38B |
| UniCredit | 24.85B |
| Prysmian | 19.49B |
| Leonardo S.p.a. | 18.70B |